Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

15.0K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
15.0K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

1.7K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.7K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

1.1K
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.1K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

4.0K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Applicability of the direct parameters of bioelectrical impedance in assessing nutritional status and surgical complications of women with gynecological cancer.

European journal of clinical nutrition·2017
Same author

Impact of perioperative care on the post-operative recovery of women undergoing surgery for gynaecological tumours.

European journal of cancer care·2016
Same author

Vitamin A deficiency in patients with hepatitis C virus-related chronic liver disease.

The British journal of nutrition·2011
Same journal

Evaluating the role of survivorship care plans in modifying disparities in health status among female cancer survivors in Maryland.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Personal pathways to success: an innovative program to overcome cancer patient barriers to tobacco cessation and promote patient participation.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Association of social determinants of health and physical functioning among breast cancer survivors.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Symptoms experienced during the first 4 months of chemotherapy administration: a longitudinal cohort study in an Australian cancer treatment unit.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Diagnosis and management of immune checkpoint inhibitor-induced dry mouth and salivary gland dysfunction in oncology patients: a systematic review.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Validation of predictive and concurrent validity of global leadership initiative on malnutrition nutritional risk screening using PNI, ALI, and GNRI as alternative tools in patients with cancer.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
See all related articles

Related Experiment Video

Updated: Feb 20, 2026

Measurement of Spatial Stability in Precision Grip
09:36

Measurement of Spatial Stability in Precision Grip

Published on: June 4, 2020

3.6K

Does grip strength decrease in the very early stages of hematological treatment?

C G C Teodozio1, G V Chaves2, I P Arcuri3

  • 1Program of Molecular Carcinogenesis, Brazilian National Cancer Institute, Andre Cavalcanti Av. 37, Rio de Janeiro, 20231-050, Brazil.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|October 24, 2017
PubMed
Summary
This summary is machine-generated.

Hematological cancer patients experience grip strength loss early in treatment. This early muscle weakness, detected within the first week, highlights the need for further research in oncology care.

Keywords:
CancerHematologyMuscle strengthPhysical function

More Related Videos

Measuring the Motor Aspect of Cancer-Related Fatigue using a Handheld Dynamometer
07:22

Measuring the Motor Aspect of Cancer-Related Fatigue using a Handheld Dynamometer

Published on: February 20, 2020

6.3K
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

20.5K

Related Experiment Videos

Last Updated: Feb 20, 2026

Measurement of Spatial Stability in Precision Grip
09:36

Measurement of Spatial Stability in Precision Grip

Published on: June 4, 2020

3.6K
Measuring the Motor Aspect of Cancer-Related Fatigue using a Handheld Dynamometer
07:22

Measuring the Motor Aspect of Cancer-Related Fatigue using a Handheld Dynamometer

Published on: February 20, 2020

6.3K
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

20.5K

Area of Science:

  • Oncology
  • Hematology
  • Clinical Medicine

Background:

  • Muscle weakness is a significant concern in hematological cancer patients, predicting poor treatment outcomes.
  • Early-stage strength loss during cancer treatment is not well-documented.
  • Handgrip strength is a key indicator of overall muscle function.

Purpose of the Study:

  • To investigate handgrip strength changes in the initial phase of hematological cancer treatment.
  • To determine if significant strength loss occurs within the first week of treatment.
  • To provide evidence for early detection and intervention strategies.

Main Methods:

  • Grip strength measurements were taken in hematological cancer patients at the start of treatment.
  • Data analysis focused on changes observed within the first 7 days of therapy.
  • Statistical significance was assessed to confirm observed strength decrements.

Main Results:

  • Grip strength was significantly compromised within the first 7 days of hematological treatment.
  • A mean decrease of 2.3 kg in grip strength was observed (P = 0.002).
  • This represents a novel finding in the early stages of cancer therapy.

Conclusions:

  • Handgrip strength declines notably within the first week of hematological treatment.
  • Early detection of muscle weakness is crucial for oncology patient management.
  • Further research is warranted on handgrip strength in patients receiving initial high-dose chemotherapy.